IVZ
32
-4
MCK
77
2
AEP
75
3
DFS
59
11
HAS
41
-5
ECL
45
-4
CL
62
-2
EXC
76
6
A
40
-3
COST
44
-3
BXP
33
-6
GE
58
-4
AON
75
-3
KO
55
-4
MAR
30
-2
CNX
50
2
CF
41
-4
M
24
-3
GM
40
-3
LOW
34
-2
IVZ
32
-4
MCK
77
2
AEP
75
3
DFS
59
11
HAS
41
-5
ECL
45
-4
CL
62
-2
EXC
76
6
A
40
-3
COST
44
-3
BXP
33
-6
GE
58
-4
AON
75
-3
KO
55
-4
MAR
30
-2
CNX
50
2
CF
41
-4
M
24
-3
GM
40
-3
LOW
34
-2
Financhill
Back

Universal Health Services Vs. Monopar Therapeutics Industry Stock Comparison

Buy
54

UHS
Universal Health Services

Last Price:
$167.51
Seasonality Move:
10.16%
Sell
29

MNPR
Monopar Therapeutics

Last Price:
$30.50
Seasonality Move:
-28.14%
Buy
54
Universal Health Services (UHS) is a Buy

Is Universal Health Services a Buy, Sell or Hold?

  • The current Universal Health Services [UHS] share price is $163.99. The Score for UHS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • UHS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $29.49. The Score for MNPR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UHS Stock Price Chart

What is Universal Health Services's stock price today?

  • The Universal Health Services share price today is $163.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UHS is experiencing slight selling pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $29.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

UHS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.65 Sell
Relative Strength Index (14 RSI): 33.57 Sell
Chaikin Money Flow: -435998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (173.31 - 187.99) Sell
Bollinger Bands (100): (177.53 - 208.07) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.49 Sell
Relative Strength Index (14 RSI): 40.75 Sell
Chaikin Money Flow: -33280 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.71 - 47.25) Sell
Bollinger Bands (100): (15.34 - 38.02) Buy

UHS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 172.25 Sell
20-day SMA: 178.43 Sell
50-day SMA: 182.88 Sell
200-day SMA: 200.19 Sell
8-day EMA: 171.63 Sell
20-day EMA: 177.06 Sell
50-day EMA: 183.2 Sell
200-day EMA: 190.25 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.32 Sell
20-day SMA: 36.52 Sell
50-day SMA: 34.82 Sell
200-day SMA: 15.16 Buy
8-day EMA: 30.92 Sell
20-day EMA: 34.18 Sell
50-day EMA: 33.46 Sell
200-day EMA: 19.84 Buy

Universal Health Services Earnings Growth & UHS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.76 per share, an increase next quarter of $0.40 per share, an increase this year of $3.14 per share, and an increase next year of $1.91 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

Universal Health Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):